ALTRI SGPS SA (ALTR.LS)       4.746  -0.07 (-1.37%)

4.746  -0.07 (-1.37%)

PTALT0AE0002 - Common Stock


Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALTR. ALTR was compared to 5 industry peers in the Paper & Forest Products industry. ALTR has a great profitability rating, but there are some minor concerns on its financial health. ALTR has a valuation in line with the averages, but on the other hand it scores bad on growth




Profitability

Profitability Rating

8

ALTR has a Return On Assets of 28.55%. This is amongst the best returns in the industry. The industry average is 14.96%. ALTR outperforms 100% of its industry peers.
ALTR's Return On Equity of 75.55% is amongst the best returns of the industry. ALTR outperforms 100% of its industry peers. The industry average return on equity is 39.25%.

ALTR's Profit Margin of 44.39% is amongst the best returns of the industry. ALTR outperforms 100% of its industry peers. The industry average Profit Margin is 14.25%.
ALTR has a Piotroski-F score of 6.00. This indicates an average health and profitability for ALTR.
VS Industry

ROA (28.55%) VS Industry: 100% outperformed.

6.19
28.55

ROE (75.55%) VS Industry: 100% outperformed.

21.57
75.55

Profit Margin (44.39%) VS Industry: 100% outperformed.

10.15
44.39

Valuation

Valuation Rating

6

The Price/Earnings Ratio is 6.24, which indicates a rather cheap valuation of ALTR.
With a Forward Price/Earnings Ratio of 9.90, the valuation of ALTR can be described as very reasonable.
ALTR's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the current price to the book value of ALTR, we can conclude it is valued correctly. It is trading at 1.72 times its book value.
ALTR's Price/Earning Ratio is slightly more expensive than the industry average, which is at 6.24.
Compared to an average industry price book ratio of 1.27, ALTR is valued more expensive than its industry peers.
VS Industry

Price/Earnings (6.24) VS Industry: 33% outperformed.

7.17
4.10

Price/Book (1.72) VS Industry: 25% outperformed.

1.87
0.90

Growth

Growth Rating

3

ALTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.08%, which is quite impressive.
The Revenue has grown by 39.56% in the past year. This is a very strong growth!
Measured over the past 5 years, ALTR shows a small growth in Earnings Per Share. The EPS has been growing by 9.96% on average per year.
ALTR is expected to show a decrease in Earnings Per Share. In the coming 5 years, the EPS will decrease by -7.97% yearly.

ALTR shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 5.33% yearly.
Based on estimates for the next 5 years, ALTR will show a decrease in Revenue. The Revenue will decrease by -1.95% on average per year.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS9.96% -13.99% 54.08% 33.55% -11.42% -12.35% -7.97%
Revenue5.33% 0.36% 39.56% 15.93% 0.95% -2.37% -1.95%

Health

Health Rating

5

The Altman-Z score of ALTR is much better than the industry average of 1.88.
A Current Ratio of 1.40 indicates that ALTR should not have too much problems paying its short term obligations.
ALTR has a Current Ratio comparable to the industry average, which is at 1.40.
ALTR has a Quick Ratio of 1.11. This is a normal value and indicates that ALTR is financially healthy and should not expect problems in meeting its short term obligations.

The Quick Ratio is in line with the industry averages, which is at 1.11.
ALTR has an Altman-Z score of 2.29. This is not the best score and indicates that ALTR is in the grey zone with still only limited risk for bankruptcy at the moment.
The Piotroski-F score of ALTR is 6.00. This is a neutral score and indicates average health and profitability for ALTR.
ALTR has one of the worst Debt to Equity ratios in its industry. 100% of its industry peers require less debt for financing their operations.
VS Industry

Debt/Equity (0.94) VS Industry: 0% outperformed.

0.94
0.45

Quick Ratio (1.11) VS Industry: 50% outperformed.

0.59
1.58

Current Ratio (1.4) VS Industry: 50% outperformed.

1.03
2.01

Altman-Z (2.29) VS Industry: 75% outperformed.

0.76
2.78

Dividend

Dividend Rating

6

With a Yearly Dividend Yield of 5.25%, ALTR is a good candidate for dividend investing.
ALTR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.61.
ALTR pays out 18.49% of its income as dividend. This is a sustainable payout ratio.

With a Dividend Yield of 5.25, ALTR pays less dividend than the industry average, which is at 9.00. 100% of the companies listed in the same industry pay a better dividend than ALTR!
The dividend of ALTR decreases each year by -48.21%.
ALTR's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
VS Industry

Dividend Yield (5.25%) VS Industry: 0% outperformed.

5.25
10.26

ALTRI SGPS SA4.746

ELI:ALTR (3/31/2023, 7:00:00 PM)-0.07 (-1.37%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap973.56M
Analysts76.67
Price Target6.68 (40.75%)
Dividend
Industry RankSector Rank
Dividend Yield 5.25%
Dividend Growth(5Y)-48.21%
DP18.49%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.72%
Min EPS beat(2)-25.49%
Max EPS beat(2)40.93%
EPS beat(4)1
Avg EPS beat(4)-3.21%
Min EPS beat(4)-26.92%
Max EPS beat(4)40.93%
Revenue beat(2)2
Avg Revenue beat(2)3.08%
Min Revenue beat(2)2.47%
Max Revenue beat(2)3.69%
Revenue beat(4)2
Avg Revenue beat(4)-8.15%
Min Revenue beat(4)-35.06%
Max Revenue beat(4)3.69%
PT rev (1m)0%
PT rev (3m)-5.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-7.83%
EPS NY rev (3m)-7.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.33%
Revenue NY rev (1m)1.13%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE 6.24
Fwd PE 9.9
P/S 1.01
P/FCF 8.48
P/OCF 5.76
P/B 1.72
P/tB 3.24
EV/EBITDA N/A
EPS(TTM)0.76
EY16.01%
EPS(NY)0.48
Fwd EY10.1%
FCF(TTM)0.56
FCFY11.79%
OCF(TTM)0.82
OCFY17.36%
SpS4.7
BVpS2.76
TBVpS1.47
PEG (NY)0.19
PEG (5Y)0.63
Profitability
Industry RankSector Rank
ROA 28.55%
ROE 75.55%
ROIC 13.63%
ROICexc 16.34%
ROICexgc 22.6%
OM 19.76%
PM 44.39%
GM 31.13%
ROICexgc(3y)10.87%
ROICexcg growth 3Y-35.1%
ROICexcg growth 5Y-13.4%
ROICexc(3y)7.91%
ROICexc growth 3Y-29.01%
ROICexc growth 5Y-8.88%
OM growth 3Y-12.54%
OM growth 5Y1.42%
PM growth 3Y-13.37%
PM growth 5Y5.07%
GM growth 3Y-7.87%
GM growth 5Y0.26%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 5.51
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality 26.84%
Current Ratio 1.4
Quick Ratio 1.11
Altman-Z 2.29
F-Score6
WACC7.88%
ROIC/WACC2.87
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Profit Quality(3y)207.53%
Profit Quality(5y)167.52%
Growth
EPS 1Y54.08%
EPS 3Y-13.99%
EPS 5Y9.96%
EPS growth Q2Q0%
EPS Next Y33.55%
EPS Next 2Y-11.42%
EPS Next 3Y-12.35%
EPS Next 5Y-7.97%
Revenue growth 1Y39.56%
Revenue growth 3Y0.36%
Revenue growth 5Y5.33%
Revenue growth Q2Q30.63%
Revenue Next Year15.93%
Revenue Next 2Y0.95%
Revenue Next 3Y-2.37%
Revenue Next 5Y-1.95%
EBIT growth 1Y50.77%
EBIT growth 3Y-12.23%
EBIT growth 5Y6.82%
EBIT Next Year53.21%
EBIT Next 3Y-2.5%
EBIT Next 5Y-0.08%
FCF growth 1Y-8.01%
FCF growth 3Y5.01%
FCF growth 5Y23.43%
OCF growth 1Y1.81%
OCF growth 3Y3.7%
OCF growth 5Y20.89%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext